LIST OF SCIENTIFIC PRESENTATIONS

  MONDAY, MAY 17, 1999

OPENING CEREMONY
Chairperson: J.S. Borer, New York NY, USA

GREETINGS
Asher Kimchi, USA
Founder and Chairman, International Academy of Cardiology
1st International Congress on Heart Disease

Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Diagnostic Methods
International Academy of Cardiology
1st International Congress on Heart Disease

Clive Rosendorff, USA
Member, Scientific Executive Committee
Chairman, Section of Molecular Cardiology, Basic Research
International Academy of Cardiology
1st International Congress on Heart Disease

Uri Elkayam, USA
Member, Scientific Executive Committee
Chairman, Section of Heart Failure
International Academy of Cardiology
1st International Congress on Heart Disease

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiac Surgery
International Academy of Cardiology
1st International Congress on Heart Disease

OPENING LECTURE:
Chairperson: M. Gheorghiade, Chicago IL, USA

09:30 OPENING LECTURE

INTRODUCTION
M. Gheorghiade, Chicago IL, USA
Member, Scientific Executive Committee
Chairman, Section of Coronary Artery Disease
International Academy of Cardiology
1st International Congress on Heart Disease

09:35 OPENING LECTURE
NEW CONCEPTS CONCERNING THE CELL BIOLOGY OF VULNERABLE PLAQUES
J.S. Forrester, Los Angeles CA, USA

MONDAY, MAY 17, 1999

10:45 - 12:30 HALL A

PL01: Plenary Session
MOLECULAR CARDIOLOGY, GENE THERAPY
Chairpersons: J.L. Mehta, Gainesville FL, USA
                                R.J.A. Trent, Camperdown, Australia

10:45 MODIFYING GENETIC FACTORS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B. Yu, R.W. Jeremy, D.R. Richmond, R.J. Trent, Camperdown, Australia

11:00 MOLECULAR GENETICS OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
L. Fananapazir, Bethesda MD, USA

11:15 VASCULAR GENE THERAPY USING TISSUE INHIBITORS OF METALLOPROTEINASES (Invited Lecture)
A.C. Newby, A.H. Baker, S.J. George, C.T. Lloyd, G.D. Angelini, Bristol, UK

11:30 ENGINEERING SKELETAL MYOBLASTS TO CIRCUMVENT IMMUNE REJECTION
J.M. Meuchel, T.R. Jones, D.A. Taylor, Durham NC, USA

11:45 ADENOVIRAL-MEDIATED MYOCARDIAL EXPRESSION OF A b-ADRENERGIC RECEPTOR TRANSGENE IMPROVES IN VIVO CARDIAC FUNCTION: A COMPARISON OF IMMUNOSUPPRESSION STRATEGIES
J.A. Hata, D.C. White, A.S. Shah, D.D. Glower, W.J. Koch, Durham NC, USA

12:00 THE ROLE OF ANGIOTENSIN II RECEPTOR EXPRESSION IN ISCHEMIA-REPERFUSION INJURY AND THE ROLE OF GENE THERAPY THEREIN (Invited Lecture)
J. Mehta, M.I. Phillips, B.C. Yang, Gainesville FL, USA

12:15 A GENOME-BASED STRATEGY FOR IDENTIFYING GENES ASSOCIATED WITH CARDIAC HYPERTROPHY AND HEART FAILURE (Invited Lecture)
A.A. Dempsey, C-C. Liew, Toronto ONT, Canada

12:30 L u n c h B r e a k

PL02: Plenary Session
NEW DEVELOPMENTS IN ECHOCARDIOGRAPHY AND INTRA CORONARY DOPPLER
Chairpersons: D.J. Sahn, Portland OR, USA
                                J.D. Thomas, Cleveland, OH, USA

10:45 ADVANCES IN ECHO ARCHITECTURE: NEW HORIZONS FOR NONINVASIVE DIAGNOSIS (Invited Lecture)
D. Sahn, Portland OR, USA

11:00 NEW ECHO METHODS FOR ASSESSING DIASTOLIC FUNCTION (Invited Lecture)
J.D. Thomas, Cleveland OH, USA

11:15 THE ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN PATIENTS WITH ATRIAL FIBRILLATION: ITS ROLE IN RISK STRATIFICATION FOR THROMBOEMBOLISM AND SUCCESSFUL CARDIOVERSION (Invited Lecture)
R. Grimm, Cleveland OH, USA

11:30 THE ROLE OF 3D ECHOCARDIOGRAPHY IN VALVULAR HEART DISEASE (Invited Lecture)
F.J. Pinto, Lisbon, Portugal

11:45 NOVEL THREE-DIMENSIONAL ECHOCARDIOGRAPHY FOR VOLUMETRIC ASSESSMENT IN ONE CARDIAC CYCLE
T.S.M. Tsang, N.M. Rajamannan, Y. Agmon, M.E. Hagen, A. Joseph Jr., B.K. Khandheria, I. Meissner, J.B. Seward, Rochester MN, USA

12:00 ANGIOGRAPHIC CORONARY SLOW FLOW PHENOMENON INDICATES MICROVASCULAR DYSFUNCTION: STUDY WITH INTRACORONARY DOPPLER (Invited Lecture)
J. Ge, D. Baumgart, J. Qian, G. Gorge, M. Haude, R. Erbel, Essen, Germany

12:15 GENDER DIFFERENCES IN CORONARY SIZE ASSESSED BY INTRAVASCULAR ULTRASOUND
S.E. Sheifer, M.R. Canos, K.P. Weinfurt, U.K. Arora, F.O. Mendelsohn, B.J. Gersh, N.J. Weissman, Washington DC, USA

12:30 L u n c h B r e a k

S67: NEW APPROACHES TO SURGICAL REVASCULARIZATION, MINIMAL INVASIVE SURGERY, ANGIOGENESIS
Chairpersons: S.D. Herman, Newark NJ, USA
                                N.M. Katz, Washington, DC, USA

10:45 THERAPEUTIC ANGIOGENESIS IN ISCHEMIC MYOCARDIUM BY FIBRIN MESHWORK AND GROWTH FACTORS IN PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE IN COMBINATION WITH VINEBERG PROCEDURE
W.D. Johnson, N.N. Kipshidze, Milwaukee WI, USA

11:00 PREOPERATIVE AND INTRAOPERATIVE BRAIN SPECT IMAGING: PREDICTORS OF NEUROLOGIC INJURY DURING OPEN HEART SURGERY
R.A. Hall, J.H. Holmes, D. Fordyce, M. Lee, R.P. Anderson, W.G. Campbell, R. Lee, Seattle WA, USA

11:15 A DIFFERENTIATED CONCEPT FOR THE TREATMENT OF CORONARY ARTERY DISEASE USING A VARIETY OF MINIMALLY INVASIVE SURGICAL TECHNIQUES
R. Cichon, M. Knaut, V. Gulielmos, T. Ahmadzade, T. Jost, S. Schueler, Dresden, Germany

11:30 REPAIR OF LLIAC ANEURYSM BY ENDOVASCULAR ENDOPROSYSTEM I: THE FRENCH EXPERIENCE
J.M. Cardon, A. Cardon, N. Mangialardi, A. Joyeux, D. Noblet, V. Vidal, T. Nguyen, Nimes, France

11:45 A HIGH MID-TERM GRAFT PATENCY RATE OBTAINED WITH A NEW NO-TOUCH SAPHENOUS VEIN GRAFT FOR CABG
D. Souza, H. Skoglund, G. Johansson, D. Filbey, V. Bomfim, Orebro, Sweden

12:00 PSEUDOANEURYSM OF THE FEMORAL ARTERY: TREATMENT BY THROMBIN INJECTION
H. Sievert, W. Pfeil, A. Baser, A. Fach, H. Merle, H. Spies, R. Ensslen, R. Schrader, D. Scherer, Frankfurt, Germany

12:15 CLINICAL EXPERIENCE AND ANGIOGRAPHIC OUTCOME OF PATIENTS UNDERGOING MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFT BY INFERIOR MINISTERNOTOMY TECHNIQUE
F. Guerra, L. Menicanti, E. Mossutto, G. Sangiorgi, L. Inglese, A. Frigiola, Milan, Italy

12:30 OFF-PUMP SURGERY FOR SINGLE- AND MULTIVESSEL CORONARY ARTERY DISEASE
R. Cichon, V. Gulielmos, M. Knaut, T. Jost, S. Schueler, Dresden, Germany

12:45 MINIMALLY TRAUMATIC CARDIAC SURGERY AN APPROACH TO REDUCE MORBIDITY AND LENGTH OF STAY
S.D. Herman, R. Sahni, C. Delacruz, A. Shehadeh, T. Schwarz, M. Farzin Aliasghapour, J. Haft, D. Bregman, Newark NJ, USA

13:00 LONG-TERM FUNCTIONAL CONSEQUENCES OF RADIAL ARTERY REMOVAL: ECHO-DOPPLER AND TRANSCUTANEOUS OXIMETRY ASSESSMENT
P. Pola, M. Serricchio, P. Tondi, M. Gaudino, D. De Martini, A. Gasbarrini, L. Gerardino, R. Pola, A. Santoliquidido, G.F. Possati, Rome, Italy

13:15 L u n c h B r e a k

MONDAY, MAY 17, 1999

S57: SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION
Chairpersons: H.R. Superko, San Mateo CA, USA
                                H.J. Geschwind, Creteil, France

10:45 IS THE MINIMAL MYOCARDIAL DAMAGE A NEW DIFFERENT ENTITY IN ACUTE CORONARY SYNDROME?
E.R. Perna, S.M. Macin, V. Mayans, J.P. Cimbaro Canella, D. Tacchi, M. Chacon, M.M. Civetta, E.F. Farias, S.M. Ruveda, J.R. Badaracco, Corrientes, Argentina

11:00 SMOKING CESSATION, BUT NOT SMOKING REDUCTION, REDUCES PLASMA HOMOCYSTEINE LEVELS
M. Bushara, P.E. McBride, D.E. Jorenby, T.B. Baker, M.C. Fiore, J.H. Stein, Madison WI, USA

11:15 THE EFFECT OF OBESITY ON LDL-CHOLESTEROL LEVELS IN AMERICAN INDIANS: THE STRONG HEART STUDY
D. Hu, J. Hannah, K.A. Jablonski, B.V. Howard, Washington DC, USA

11:30 REDUCTION IN TIME DOMAIN INDICES OF HEART RATE VARIABILITY FOLLOWING CAROTID ENDARTERECTOMY OR CAROTID ANGIOPLASTY
R.P. Steeds, A. Sivaguru, K. English, K.S. Channer, Sheffield, UK

11:45 DOES HEALTH AFFECT DRINKING BEHAVIOR? PRELIMINARY FINDINGS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY, 1987-95
M. Eigenbrodt, F. Fuchs, R. Hutchinson, C. Paton, D. Goff, D. Couper, Chapel Hill NC, USA

12:00 ST DEPRESSION AND NEW LBBB ARE PREDICTORS OF INCREASED IN-HOSPITAL MORTALITY IN ACUTE MYOCARDIAL INFRACTION
R.S. Wright, W.L. Miller, J.P. Grill, S.L. Kopecky, F. Sgura, S. Asirvathamm, Rochester MN, USA

12:15 GRAPHICAL PLOTTING OF FRAMINGHAM RISK SCORES FOR OFFICE USE
J.G. Keevil, P. McBride, Madison WI, USA

12:30 THE PROGNOSTIC ROLE OF BIPHASIC RESPONSE DURING DIPYRIDAMOLE - ECHOCARDIOGRAPHY TEST IN PATIENTS AFTER UNCOMPLICATED ACUTE MYOCARDIAL INFARCTION
M. Radosavljevic, Z. Vasiljevic, N. Radovanovic, A. Karadzic, J. Kostic, V. Vukcevic, P. Mitrovic, D. Babic, T. Jozic, M.M. Nesovic, Belgrade, Yugoslavia

12:45 L u n c h B r e a k

MONDAY, MAY 17, 1999

S62: CARDIOMYOPATHY AND HEART FAILURE, MECHANISMS AND MANAGEMENT
Chairpersons: N.J. Angomachalelis, Thessaloniki, Greece
                                D.R. Nul, Buenos Aires, Argentina

10:45 CARDIAC INVOLVEMENT IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME: A MULTICENTER CLINICAL-PATHOLOGIC-STUDY
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy

11:00 MODIFICATION OF POST-INFARCTION REMODELING USING ANGIOTENSIN II RECEPTOR BLOCKADE
B.I. Jugdutt, Edmonton, Alberta, Canada

11:15 IMMUNOADSORPTION IMPROVES CARDIAC PERFORMANCE IN PATIENTS WITH SEVERE DILATED CARDIOMYOPATHY
J. Mueller, G. Wallukat, M. Dandel, H. Bieda, M. Hummel, R. Hetzer, Berlin, Germany

11:30 THREE DECADES OF FOLLOW-UP OF 1.196 CHAGAS DISEASE PATIENTS WITH COMPLETE AV BLOCK HEART FAILURE AND PACING
O.T. Greco, A. Cardinalli Neto, R. Costa, J. Vitola, S.A.C. Garzon, A.M. Lorga, R.V. Ardito, Sao Paulo, Brazil

11:45 INCIDENCE OF CARDIOMYOPATHY AND DETECTION OF HIV IN MYOCARDIAL CELLS OF HIV-POSITIVE PATIENTS
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy

12:00 DIFFERENT BASELINE SYMPATHO-VAGAL BALANCE AND IMPAIRED AUTONOMIC RESPONSIVENESS IN ISCHEMIC AND IDIOPATHIC CARDIOMYOPATHY
G. Malfatto, M. Facchini, L. Sala, G.B. Perego, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy

12:30 L u n c h B r e a k

MONDAY, MAY 17, 1999

P111: Poster Session
THE PLAQUE AND ACUTE CORONARY SYNDROME

Board No.

1 PLAQUE INFLAMMATION OCCURS IN THE ENTIRE CORONARY TREE OF PATIENTS DIED BY ACUTE MYOCARDIAL INFARCTION
A. Mauriello, E. Bonanno, G. Sangiorgi, G. Palmieri, L. Anemona, L.G. Spagnoli, Rome, Italy

2 LINKS BETWEEN CAROTID AND CORONARY ATHEROSCLEROSIS
Z. Huang, L. Gong, Z. Shi, Guangzhou, China

3 VULNERABILITY OF A PLAQUE SEARCHED BY NONINVASIVE, NOVEL DOPPLER TECHNIQUE
Y. Koiwa, H. Kanai, H. Hasegawa, H-I. Kamada, H. Chikama, K. Shirato, N. Chubachi, E. Fusimi, M. Hayashi, Sendai, Japan

4 MELATONIN IN PATIENTS WITH CORONARY ARTERY DISEASE, HYPERTENSIVE HEART DISEASE AND DILATED CARDIOMYOPATHY
P. Lercher, K. Stoschitzky, A. Sakotnik, P. Liebmann, W. Klein, Graz, Austria

5 EVOLUTION OF ACUTE CORONARY SYNDROME: A COMPARISON BETWEEN UNSTABLE ANGINA, NON-Q WAVE INFARCTION AND Q WAVE INFARCTION
E.R. Perna, S.M. Macin, J.P. Cimbaro Canella, V. Mayans, D. Tacchi, M. Chacon, J. Parras, E.F. Farias, M. Caceres, J.R. Badaracco, Corrientes, Argentina

6 A PRELIMINARY STUDY ON THE PROGNOSTIC VALUE OF TRANSIENT ISCHEMIA FOUND IN 24-HOUR MONITORING IN PATIENTS WITH UNSTABLE ANGINA
O.A. Najos, F. Enrique, B. Posas, A.A. Miranda, M.A.S. Lao, W.G. Dee, M.A.M. Iboleon, R.D. Saavedra, H.B. Calleja, Manila, Philippines

7 DIFFERENCE IN THE IN-HOSPITAL CASE-FATALITY RATE OF UNSTABLE ANGINA BETWEEN MEN AND WOMEN
L.C.S. Passos, A.A. Lopes, U. Costa, L. Nascimento, N. Lobo, A. Rabelo Jr., Salvador, Brazil

8 ACUTE CORONARY SYNDROMES - DIFFERENCE BETWEEN PATIENTS WITH OBSTRUCTIVE AND NORMAL CORONARY ARTERIES
L.C.S. Passos, A.C. Lopes, A.L. Rosario, N.O. Filho, R.V. Boss, A. Neri, A.R. Junior, Salvador, Brazil

9 CHLAMYDIA PNEUMONIAE INFECTION AND ATHEROSCLEROTIC CORONARY DISEASE
M. Penco, A. Varveri, L. Sgorbini, A. Dagianti, E. Biffani, S. Romano, A. Dagianti, R. Sessa, M. Di Pietro, M. Del Piano, Rome, Italy

10 DOES THE CORONARY ARTERY SPASM LEAD TO ATHEROSCLEROTIC STENOSIS? LONG-TERM FOLLOW-UP OF PATIENTS WITH VASOSPASTIC ANGINA
M. Watarai, H. Horibe, F. Matsubara, K. Takemoto, S. Shimizu, Y. Shiga, F. Takatsu, Aichi, Japan

MONDAY, MAY 17, 1999

P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTS

Board No.

11 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TOTAL CORONARY OCCLUSION: THE EFFECT OF RESTENOSIS ON LEFT VENTRICULAR FUNCTION
T. Tukek, V. Akkaya, A.B. Sozen, S. Demirel, Y. Nisanci, Instanbul, Turkey

12 DIRECT CORONARY STENTING WITHOUT PREVIOUS BALLOON ANGIOPLASTY
A. Albarran, F. Hernandez, R. Gascuena, J. Tascon, P. Hernandez, M. Lazaro, J. Andreu, M. Alonso, Madrid, Spain

13 ELECTIVE AND NON-ELECTIVE INTRACORONARY STENTING: PROSPECTIVE COMPARISON OF CLINICAL OUTCOME
F.R. Amin, M. Yousufuddin, R.H. Stable, D. Francis, W. Shamim, A.S. Kurban, J.S. Clague, U. Sigwart, London, UK

14 FEMORAL HAEMOSTASIS AFTER TRANSCATHETER THERAPEUTIC INTERVENTION: A PROSPECTIVE RANDOMISED STUDY OF ANGIO-SEAL VS FEMOSTOP
F.R. Amin, M. Yousufuddin, W. Shamim, R.H. Stables, J. Clague, A.S. Kurban, U. Sigwart, London, UK

15 EFFECTS OF DIFFERENT DILATATION-PRESSURES ON THE EXPANSION OF CORONARY STENTS - A COMPARATIVE POSTMORTAL HISTOMORPHOLOGICAL AND MORPHOMETRICAL STUDY
T. Deneke, K.-M. Mueller, J. Barmeyer, S. Holt, P.H. Grewe, Bochum, Germany

16 SURFACE-STRUCTURE OF 30 DIFFERENT CORONARY STENTS - A SEM AND MORPHOMETRICAL ANALYSIS
K.-M. Muller, T. Deneke, A. Machraoui, S. Holt, J. Barmeyer, P.H. Grewe, Bochum, Germany

17 CHARACTERISTICAL MORPHOLOGICAL FINDINGS AFTER CORONARY STENTING - A HISTOLOGICAL STUDY AFTER POSTMORTEM AND INTRAVITAL STENTING
P.H. Grewe, J. Barmeyer, T. Deneke, S. Holt, K.-M. Mueller, Bochum, Germany

18 EMERGENCY REVASCULARIZATION AND HYBRID APPROACHES IN CARDIOGENIC SHOCK
F. Hernandez, P. Hernandez, J.C. Tascon, A. Albarran, M. Alonso, J. Andreu, R. Gascuena, M. Lazaro, J.E. Rodriguez, J.J. Rufilanchas, Madrid, Spain

19 SEVEN YEARS' FOLLOW-UP OF 181 CASES OF PRIMARY PTCA
Z. Huang, Y. Hou, M. Jia, Y. Liu, P. Wu, D. Xu, Guangzhou, China

20 PERCUTANEOUS CORONARY INTERVENTION (PCI) IN ELDERLY PATIENTS WITH ACUTE MI
N.M. Keller, V. Lazo de la Vega, F. Feit, H. Winer, New York NY, USA

21 NEW NITINOL STENT FOR PERCUTANEOUS TREATMENT OF BIFURCATED LESIONS: RESULTS OF A PRELIMINARY STUDY
J.C. Laborde, J.R. Seguin, J. Fajadet, B. Cassagneau, J. Marco, Toulouse, France

MONDAY, MAY 17, 1999

P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTS (cont)

Board No.

22 NOR-I, A BIODEGRADABLE METAL FOR CARDIOVASCULAR IMPLANTS. IN VITRO BIOCOMPATIBILITY AND MECHANICAL PROPERTIES
M. Peuster, P. Wuebbolt, H. Brauer, A. Fischer, G. Hausdorf, Hannover, Germany

23 IMPLANTATION OF ePTFE COVERED STENTS IN PATIENTS WITH SAPHENOUS VEIN GRAFT DISEASE: ACUTE AND LONG-TERM FOLLOW-UP
G. Sangiorgi, P. Cioffi, M. Medda, S. Castelvecchio, L. Inglese, Milano, Italy

24 THE EFFECT OF CORONARY STENT IMPLANTATION ON PLASMA PLATELET - ACTIVATING FACTOR LEVELS
C. Sekuri, H. Kultursay, L. Can, M. Kayikcioglu, M. Zoghi, O. Yavuzgil, S. Payzin, Izmir, Turkey

25 THE EFFECT OF STENT IMPLANTATION PRESSURE ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE ARTERIO-ARTERIAL EX-VIVO SHUNT MODEL
S. Sukavaneshvar, Y. Zheng, J. Danforth, M. Williams, K.A. Solen, F. Mohammad, Provo UT, USA

26 OUTCOME OF URGENT CORONARY INTERVENTIONS IN PATIENTS PRESENTING WITH ACUTE NON-Q-WAVE MYOCARDIAL INFARCTION IN A COMMUNITY HOSPITAL SETTING
R. Wolyn, P. Chowdhury, G.C. Timmis, J.A. Goldstein, W.W. O'Neill, Royal Oak MI, USA

 

MONDAY, MAY 17, 1999

P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONS

Board No.

27 LP STENT IN A PORCINE MODEL
A. Popov, S. Kaul, N. Sinaii, P.K. Shah, P. Barath, Los Angeles CA, USA

28 HPA-3 POLYMORPHISM OF THE PLATELET FIBRINOGEN RECEPTOR IS NOT ASSOCIATED WITH AN INCREASED RISK OF THROMBOSIS OR RESTENOSIS AFTER CORONARY STENT PLACEMENT
C. Bottiger, A. Kastrati, W. Koch, J. Mehilli, N.V. Beckerath, A. Schoemig, Munich, Germany

29 ANTIPLATELET AND ANTICOAGULANT THERAPY IN POST-STENTING PATIENTS
Y. Hou, Z. Huang, Y. Liu, M. Jia, Guangzhou, China

MONDAY, MAY 17, 1999

P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONS (cont)

Board No.

30 ADMINISTRATION OF CILOSTAZOL THERAPY AFTER SUCCESSFUL CORONARY STENT IMPLANTATION WAS USEFUL FOR THE PREVENTION OF RESTENOSIS
T. Kunishima, H. Musha, T. Iwasaki, J. Nagahima, Y. Masui, T. So, T. Nakamura, M. Sakakibara, H. Tochiki, M. Murayama, Kawasaki, Japan

31 REOPRO DOSAGE REGIMENS: CONFUSION OVER THE INFUSION TO ENHANCE PERFUSION?
D.J. Price, H. Bunce, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

32 ABCIXIMAB IN CORONARY STENTING: ROUTINE USE CANNOT BE JUSTIFIED
D.J. Price, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

33 REALISTIC USE OF ABCIXIMAB IN PERCUTANEOUS CORONARY INTERVENTION
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

34 THE EFFECT OF ABCIXIMAB AND WEIGHT-ADJUSTED HEPARIN ON ACTIVATED CLOTTING TIME IN ASIAN PATIENTS
H.C. Tan, Y.T. Lim, T.C. Yeo, T.T. Lim, A. Cheng, B.L. Chia, Singapore, Singapore

 

MONDAY, MAY 17, 1999

P122: Poster Session
HYPERTENSION, BASIC AND CLINICAL

Board No.

35 EFFECT OF ANTIPLATELET DRUGS ON ULTRASOUND-INDUCED AGGREGATIONOF PLATELETS IN VITRO
I.E. Adzerikho, A.G. Mrochek, A.B. Samal, Minsk, Belarus

36 EFFECTS OF TIME INTAKE OF TRANDOLAPRIL ON HEART RATE VARIABILITY AND BLOOD PRESSURE VALUES IN MODERATE ESSENTAIL HYPERTENSION
A. Campeanu, V. Teodorescu, Bucharest, Romania

37 AMBULATORY BLOOD PRESSURE MONITORING AND TARGET-ORGAN DAMAGE IN ESSENTIAL HYPERTENSION
H. Chen, B. Yuru, Y. Liuqin, Fuzhou, China

MONDAY, MAY 17, 1999

P122: Poster Session
HYPERTENSION, BASIC AND CLINICAL (cont)

Board No.

38 MICROCIRCULATION REACTIVITY IN NORMOTENSIVE SUBJECTS WITH A FAMILIAL PREDISPOSITION TO HYPERTENSION
J. Maver, M. Strucl, Ljubljana, Slovenia

39 EXERCISE PERFORMANCE IN HYPERTENSIVES: FELODIPINE VS CILAZAPRIL CROSS-OVER STUDY
G. Parrinello, S. Paterna, A. Pinto, P. Amato, E. Capodieci, A. Tuttolomondo, T. Maniscalchi, A. Bova, V. Accardo Palumbo, G. Follone, A. Ortoleva, G. Licata, Palermo, Italy

MONDAY, MAY 17, 1999

P125: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSIS

Board No.

40 THE ELECTROCARDIOGRAM IN MORBID OBESITY
M.A. Alpert, B.E. Terry, Mobile AL, USA

41 THE EFFECT OF THE K ⁺ AGONIST NICORANDIL ON PERIPHERAL VASCULAR RESISTANCE
M. Brodmann, U. Haiden, L. Schwarzl, R. Gasser, G. Stark, E. Pilger, Graz, Austria

42 USE OF STRESS DUPLEX AND ANKLE BRACHIAL INDEX IN THE ASSESSMENT OF PERIPHERAL VASCULAR DISEASE IN PATIENTS WITH DIABETES MELLITUS
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E. del Fuerte, Manila, Philippines

43 INFLUENCE OF DIABETES MELLITUS ON EARLY OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil

44 CORONARY ARTERY DISEASE IN DIABETIC WOMEN: COMPARISON OF THE SEVERITY OF CORONARY ARTERY DISEASE IN INSULIN DEPENDENT AND NON-INSULIN DEPENDENT DIABETIC WOMEN BY CORONARY ANGIOGRAPHY
A.M. Radwan, H.A. Hajar, Doha, Qatar

45 SILENT MYOCARDIAL ISCHAEMIA IN DIABETIC PATIENTS
M. Negrusz-Kawecka, J. Moszczynska-Stulin, D. Zytkiewicz-Jaruga, P. Salomon, Wroclaw, Poland

46 EFFECT OF HIGH FIBRE, LOW FAT DIET IN THE PREVENTION OF CORONARY ARTERY DISEASE IN DIABETICS
R. Sharma, New Delhi, India

47 DURATION OF DIABETES AFFECTS CARDIAC FUNCTION IN ASYMPTOMATIC, NORMOTENSIVE TYPE 2 DIABETES
B.H. Sung, K. Shah, S. Kidambi, M.F. Wilson, Buffalo NY, USA

MONDAY, MAY 17, 1999

P127: Poster Session
PRIMARY PREVENTION OF CORONARY ARTERY DISEASE

Board No.

48 HIGH ADMISSION RATES FOR PREMATURE CORONARY ARTERY DISEASE: ARE CURRENT GUIDELINES ON PRIMARY PREVENTION ADEQUATE?
K.O. Akosah, B. Gower, La Crosse WI, USA

49 THE TIME DEPENDENT EFFECT OF WATER HARDNESS ON HEART MUSCLE IN THE RATS
V. Bada, J. Kucharska, A. Gvozdjakova, Z. Braunova, j. Gvozdjak, Bratislava, Slovak Republic

50 THE FLAVONOIDS IN PROVEX CV® SIGNIFICANTLY INHIBIT EXPERIMENTAL THROMBOSIS IN STENOSED AND DAMAGED CANINE CORONARY ARTERIES
J. Folts, H. Osman, J. Reed, Madison WI, USA

51 FLAVONOIDS IN PROVEX CV®, INHIBIT HUMAN EX VIVO PLATELET AGGREGATION AND IN VITRO LDL OXIDATION
J. Folts, D. Shanmuganayagam, D. Wiebe, Madison WI, USA

52 STUDY OF HEART RATE VARIABILITY IN THE CHARACTERIZATION OF ANAEROBIC THRESHOLD (AT) IN DISCONTINUOUS DYNAMIC EXERCISE TESTS (DDET)
V.R.F.S. Maraes, E. Silva, T.F. Ribeiro, J. Petto, M.S.A. Moura, A.M. Catai, L. Oliveira, L.C. Trevelin, L. Gallo Jr., Sao Carlos, Brazil

53 ASSOCIATION OF RISK FACTORS IN A TEN-YEAR SURVEY MONICA PROGRAMME
M. Marin-Tarlea, C. Carp, E. Apetrei, I. Serban, C. Ceck, M. Patrascoiu, N. Florica, D. Mihaescu, Bucharest, Romania

54 PHYSICIAN PERSONAL COMPLIANCE TO NCEP GUIDELINES AND PRESENCE OF ADDITIONAL CAD RISK FACTORS
H.R. Superko, R.M. Krauss, P.T. Williams, San Mateo CA, USA

55 ATT (AGGREGATION, THROMBOSIS, THROMBOLYSIS) MODEL FOR TESTING PATIENTS WITH ATHEROTHROMBOTIC DISEASES, ITS PREDICTIVE, DIAGNOSTIC ROLE IN MONITORING & ASSESSING DISEASE & THERAPY IN INDIVIDUAL SUBJECTS
M.H. Wiener, F. Wiener, M. Burke, I. Yust, A. Iana, Tel Aviv, Israel

MONDAY, MAY 17, 1999

P138: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKER

Board No.

56 LOSARTAN VS. DELAPRIL IN PATIENTS WITH HEART FAILURE
O. Biadi, N. Gigli, R. Della'Anna, G. Musumeci, L. Papi, R. Mariotti, M. Mariani, Pisa, Italy

57 COMBINED TREATMENT WITH EPROSARTAN AND AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN CHRONIC HEART FAILURE
A. Lazar, A. Salajan, V. Salajan, O. Burta, L. Lazar, M. Popescu, Oradea, Romania

58 LISINOPRIL VERSUS ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART FAILURE
M. Otljanska, B. Sidovska, M. Nospal, E. Srbinovska, S. Jovanova, Skopje, Macedonia

 

MONDAY, MAY 17, 1999

P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICAL

Board No.

59 PROARRHYTHMIC EFFECTS OF FLECAINIDE DEPENDS ON CORONARY PATENCY AFTER THROMBOLYSED Q WAVE MYOCARDIAL INFARCTION
K.G. Adamian, A.V. Astvatsatrian, a.L. Chilingarian, A.Z. Garibgeanian, Yerevan, Armenia

60 HIGH-DOSE IV AMIODARONE IN THE CONVERSION TO SINUS RHYTHM OF  PAROXISMAL ATRIAL FIBRILLATION. WHEN IS IT NECESSARY?
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy

61 GENDER AND BETA-BLOCKER USE PREDICT SINUS RHYTHM MAINTENANCE AFTER ELECTIVE CARDIOVERSION FOR ATRIAL FIBRILLATION
J. Chakrabarti, S.D. Piraino, J.R. Cook, Springfield MA, USA

62 QT-DISPERSION IN PATIENTS WITH BRAIN INJURY OR SUBARACHNOID HEMORRHAGE
V. Dimitroula, G.F. Grekas, V.G. Koulouras, C.G. Siogas, D.A. Sideris, G. Nakos, Ioannina, Greece

63 APPLICATION OF HEART RATE VARIABILITY IN CHAGAS' DISEASE
A.S. Menezes Jr., C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, Goiania, Brazil

64 REACTION OF CARDIOVASCULAR SYSTEM TO THE PHYSICAL LOAD IN PATIENTS WITH ISCHEMIC HEART DISEASE, COMPLICATED BY  ATRIAL FIBRILLATION
A. Mrochek, A. Bulgak, V. Duda, A. Prystrom, M. Zakherevsky, Minsk, Belarus

65 TRANSMURAL DISPERSION OF REPOLARISATION AS A PREDICTOR OF VENTRICULAR ARRHYTHMIAS INDUCTION IN POST-MYOCARDIAL PATIENTS
A.Z. Pietrucha, D. Mroczek-Czernecka, W. Piwowarska, Cracow, Poland

MONDAY, MAY 17, 1999

P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICAL (cont)

Board No.

66 CARDIAC MANIFESTATIONS OF ACUTE CARBAMATE AND ORGANOPHOSPHATE POISONING
A.M. Saadeh, N.A. Farsakh, M.K. Al-Ali, Irbid, Jordan

67 CLINICAL CHARACTERISTICS AND LONG-TERM COURSES IN 5 PATIENTS WITH ATRIAL STANDSTILL
S. Tsuji, N. Kotooka, K. Yoshida, T. Morooka, K. Kidou, T. Ryu, K. Yoshida, T. Ogata, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan

68 THE COMBINATION OF REDUCED DOSES OF PROPAFENONE WITH MEXILETINE IS MORE EFFICACIOUS THAN PROCAINAMIDE PLUS MEXILETINE IN SUPPRESSING VENTRICULAR ARRHYTHMIAS
E. Zaimi, V. Gjini, G. Ndrepepa, E. Maci, S. Qirko, P. Cina, Tirana, Albania

 

MONDAY, MAY 17, 1999

P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATION

Board No.

69 RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FLUTTER IN HEART TRANSPLANTED PATIENTS
S. Boveda, P. Lagrange, M. Galinier, N. Prouteau, E. Espaliat, A. Lagrange, P. Massabuau, M. Delay, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France

70 INCIDENCE OF ATRIAL FIBRILATION AFTER RADIOFREQUENCY CATHETER ABLATION FOR COMMON ATRIAL FLUTTER
S. Boveda, P. Lagrange, N. Prouteau, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France

71 RECURRENCE OF ATRIAL ARRHYTHMIAS AFTER SUCCESSFUL RADIOFREQUENCY CATHETER ABLATION OF COMMON ATRIAL FLUTTER: SOME POSSIBLE FACTORS
S. Boveda, P. Lagrange, A. Pathak, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, Toulouse, France

72 LONG-TERM RESULTS OF THE SURGICAL ABLATION GUIDED BY SINUS RHYTHM INTRAOPERATIVE MAPPING IN PATIENTS WITH VENTRICULAR TACHYCARDIA AFTER MYOCARDIAL INFARCTION
J. Bytesnik, J. Pirk, V. Vancura, K. Lefflerova, Prague, Czech Republic

MONDAY, MAY 17, 1999

P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATION (cont)

Board No.

73 OBSERVATION TIME AFTER A SUCCESSFUL RADIOFREQUENCY ABLATION IN AV ACCESSORY PATHWAYS
J.A. Gomez Guindal, J.L. Merino, R. Peinado, J. Perea, A. Sanchez, N. Sobrino, J.A. Sobrino, Madrid, Spain

74 RADIOFREQUENCY CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN RIGHT VENTRICULAR CARDIOMYOPATHY. IDENTIFICATION OF THE TARGET SITES BY CONCEALED ENTRAINMENT
E.E. Lazaris, A.G. Katsivas, A.G. Manolis, C. Vassilopoulos, D. Karatza, N. Louvros, Athens, Greece

75 CORONARY SINUS ABNORMALITIES IN PATIENTS WITH PARASEPTAL PATHWAYS
K.K. Talwar, R. Juneja, A.K. Chopra, P. Kamath, New Delhi, India

 

MONDAY, MAY 17, 1999

P145: Poster Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE

Board No.

76 DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN A 12-YEAR-OLD PATIENT WITH LARGE CELL LYMPHOMA: INTERVENTIONAL RECANALIZATION WITH THE AMPLATZ THROMBECTOMY DEVICE
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany

77 LUNG FUNCTION BEFORE AND AFTER SURGERY FOR ATRIAL SEPTAL DEFECT AND TETRALOGY OF FALLOT
J. Sulc, A. Zapletal, J. Hruda, B. Hucin, M. Samanek, Prague, Czech Republic

78 BRONCHIAL HYPERREACTIVITY IN PATIENTS WITH CORRECTED CHT. COULD THESE PATIENTS DEVELOP ASTHMA?
J. Sulc, J. Hruda, A. Zapletal, B. Hucin, M. Samanek, Prague, Czech Republic

79 INTERVENTRICULAR COMMUNICATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan

MONDAY, MAY 17, 1999

PL03: Plenary Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY
Chairperson: B.J. Maron, Minneapolis MN, USA
                                D.E. Wigle, Toronto, Ontario, Canada

13:45 STRATEGIES FOR THE MANAGEMENT AND RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B.J. Maron, Minneapolis MN, USA

14:00 ASSESSMENT AND TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (Invited Lecture)
W.H. Spencer III, Houston TX, USA

14:15 HYPERTROPHIC REMODELING OF THE LEFT VENTRICLE AND THE IMPLICATIONS OF RELATIVE WALL THICKNESS (Invited Lecture)
W.H. Gaasch, Burlington MA, USA

14:30 LEFT VENTRICULAR HYPERTROPHY AND MYOCARDIAL DAMAGE (Invited Lecture)
M. Ballester, Barcelona, Spain

14:45 THE SCIENTIFIC BASIS FOR EXCESS CARDIOVASCULAR MORTALITY IN LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
G.A. Mensah, Augusta GA, USA

15:00 TREATMENT OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
P.R. Liebson, Chicago IL, USA

15:15 PATHOLOGIC FIBROSIS AND CONNECTIVE TISSUE MATRIX IN LEFT VENTRICULAR HYPERTROPHY DUE TO CHRONIC ARTERIAL HYPERTENSION IN MAN
M.A. Rossi, Sao Paulo, Brazil

15:30 C o f f e e B r e a k

MONDAY, MAY 17, 1999

PL04: Plenary Session
ARRHYTHMIAS MECHANISMS, ANTIARRYTHMIC DRUGS AND IMPLANTABLE ANTIARRYTHMIC DEVICES
Chairpersons: M.E. Cain, St. Louis MO, USA
                                B. Luderitz, Bonn, Germany

13:45 MECHANISMS OF ATYPICAL RIGHT ATRIAL FLUTTER (Invited Lecture)
J. Cheng, W. Cabeen, M.M. Scheinman, Syracuse NY, USA

14:00 RECENT ADVANCES AND FUTURE DIRECTIONS IN THE TREATMENT OF ATRIAL FIBRILLATION - PHARMACOLOGICAL AND NON-PHARMACOLOGICAL ALTERNATIVES (Invited Lecture)
G.K. Feld, San Diego, CA, USA

14:15 QUALITY OF LIFE IN ATRIAL FIBRILLATION (Invited Lecture)
B. Luderitz, W. Jung, Bonn, Germany

14:30 INCIDENCE OF SPONTANEOUS ATRIAL TACHYARRHYTHMIAS IN PATIENTS TREATED WITH A COMBINED ATRIOVENTRICULAR DEFIBRILLATOR (Invited Lecture)
W. Jung, C. Wolpert, B. Luderitz, Bonn, Germany

14:45 PARENTERAL ANTIARRHYTHMIC DRUGS FOR SUPRAVENTRICULAR OR VENTRICULAR ARRHYTHMIAS (Invited Lecture)
P. Kowey, R.A. Marinchak, S.J. Rials, D.B. Bharucha, Wynnewood PA, USA

15:00 SUDDEN DEATH AND ARRHYTHMIAS IN TRANSGENIC MOUSE MODELS OF HEART DISEASE (Invited Lecture)
J. Jalife, Syracuse NY, USA

15:15 NONINVASIVE DETECTION OF THE ELECTROPHYSIOLOGIC FINGERPRINT THAT INCREASES SUSCEPTIBILITY TO SUSTAINED VENTRICULAR ARRHYTHMIAS (Invited Lecture)
M.E. Cain, H.D. Ambos, R.M. Arthur, St. Louis MO, USA

15:30 AMIODARONE PLUS BETA BLOCKERS, FAR FROM BEWILDERMENT, IN HIGH RISK SUDDEN DEATH PATIENTS (Invited Lecture)
D.R. Nul, Buenos Aires, Argentina

15:45 NEW DETECTION ALGORITHMS IN DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (Invited Lecture)
C. Wolpert, W. Jung, B. Luederitz, Bonn, Germany

16:00 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S56: INTERVENTIONAL CARDIOLOGY: STENTS
Chairpersons: P.C. Block, Portland OR, USA
                                J.W. Moses, New York, NY, USA

13:45 IN-VIVO ASSESSMENT OF AN ACTIVATED PROTEIN C-ELUTING STENT
R.S. Foo, K. Hogrefe, J.H. Baron, D.P. de Bono, A.H. Gershlick, Leicester, UK

14:00 PERCUTANEOUS DIRECT MYOCARDIAL REVASCULARIZATION GUIDED BY BIOSENSE™ LEFT VENTRICULAR MAPPING IN PATIENTS WITH REFRACTORY CORONARY ISCHEMIC SYNDROMES
R. Kornowski, J. Moses, D.S. Baim, M.K. Hong, A. Stine, R.E. Kuntz, M.B. Leon, Washington DC, USA

14:15 THE SAFETY AND FEASIBILITY OF STENTING SMALL CORONARY ARTERIES: THE ACUTE AND MID TERM RESULTS OF BESTENT SMALL AND NIR-7
R. Moer, Y. Myreng, P. Molstad, K. Ytre-Ame, P.A. Simes, S. Golf, Feiring, Norway

14:30 REDUCED 6 MONTH ANGIOGRAPHIC RESTENOSIS RATE AFTER TREATMENT OF SAPHENOUS VEIN GRAFT DISEASE WITH THE WIKTOR HEPARIN COATED STENT
G. Van Langenhove, P. Vermeersch, D. Stockman, C. Convens, F. Van den Branden, P. Van den Heuvel, Antwerp, Belgium

14:45 CATHETER-BASED CORONARY INTERVENTIONS IN ATHEROSCLEROTIC CORONARY ARTERY ANEURYSMS: SHORT AND LONG-TERM CLINICAL OUTCOMES
S. Fuchs, R. Kornowski, H. Faraj, L.F. Satler, A.D. Pichard, A. Negoita, K.M. Kent, M.B. Leon, Washington DC, USA

15:00 CAROTID-PTA: STENT IMPLANTATION BEFORE BALLOON DILATATION MAY PREVENT THROMBOEMBOLIC COMPLICATIONS
H. Sievert, W. Pfeil, H-J. Schultze, H. Spies, H. Merle, R. Ensslen, R. Theis, K-F. Beykirch, A. Fach, C. Rubel, J. Peters, Frankfurt, Germany

15:15 STENTING OF TRUE BIFURCATION LESIONS WITH WIKTOR STENT: IMMEDIATE AND LONG TERM RESULTS
F. Airoldi, A. Anzuini, S. Rosanio, V. Legrand, H. Bonnier, M. Tocchi, M. Carlino, I. Sheiban, C. Di Mario, A. Colombo, Milan, Italy

15:30 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S66: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY / CONGENITAL HEART DISEASE
Chairpersons: M. Hauser, Munich, Germany
                                H. Sievert, Frankfurt, Germany

13:45 MORPHOMETRIC ANALYSIS OF COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan

14:00 TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE (PFO) IN 90 PATIENTS WITH SIX DIFFERENT OCCLUSION SYSTEMS
H. Sievert, U. Krumsdorf, P. Keppeler, R. Schrader, S. Rux, J. Dirks, U.U. Babic, R. Ensslen, A. Fach, H. Merle, D. Scherer, H. Spies, Frankfurt, Germany

14:15 STRESS-TESTING IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES AFTER ARTERIAL SWITCH OPERATION: EXERCISE CAPACITY, VENTRICULAR FUNCTION AND MYOCARDIAL PERFUSION
M. Hauser, A. Kuhn, S. Braun, M. Schwaiger, J. Hess, Munich, Germany

14:30 COMPARISON OF CAPTOPRIL AND PROPRANOLOL THERAPY IN INFANTS WITH SEVERE CONGESTIVE HEART FAILURE DUE TO CONGENITAL HEART DISEASE
R. Buchhorn, M. Hulpke Wette, D. Bartmus, R. Schulz, A. Wessel, J. Buersch, Goettingen, Germany

14:45 CONVERSION OF ATRIOPULMONARY OR LATERAL ATRIAL TUNNEL CAVOPULMONARY ANASTOMOSIS TO EXTRACARDIAC CONDUIT CAVOPULMONARY ANASTOMOSIS
J.A.M. van Son, H. Hess, J. Hambsch, P. Schneider, G.S. Haas, F.W. Mohr, Leipzig, Germany

15:00 PREDICTION OF PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS WITH OPERATED CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, F.C. Verhulst, H.J. Duivenvoorden, F.J. Meijboom, R.A.M. Erdman, J. Hess, Rotterdam, The Netherlands

15:15 POST REPAIR FOLLOW UP OF TETRALOGY OF FALLOT
O. Milanesi, R. Biffanti, S. Salvadori, G. Svaluto Moreolo, S. Secchieri, M. Rubino, G. Stellin, Padova, Italy

15:30 CHANGES IN SUPERIOR VENA CAVA VELOCITY PATTERNS IN NORMAL NEONATES
M. Tamura, K. Harada, G. Takada, Akita, Japan

15:45 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S53: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH I
Chairpersons: J.M. Hare, Baltimore MD, USA
                                 H. Schroder, Halle (Saale), Germany

13:45 LASER MYOCARDIAL REVASCULARIZATION ENHANCES EXPRESSION OF ANGIOGENIC CYTOKINES IN A PORCINE MODEL OF CHRONIC MYOCARDIAL ISCHEMIA
S. Fuchs, Y. Vodovotz, M.B. Leon, R. Kornowski, Washington DC, USA

14:00 INHIBITION OF RESTENOSIS BY AN ORALLY AVAILABEL CELL CYCLE INHIBITOR
J. Ruef, K. Peter, C. Bode, C. Patterson, Heidelberg, Germany

14:15 ACE INHIBITOR ENALAPRIL AND PROPIONYL-I-CARNITINE INDUCE APOPTOSIS IN RAT AORTIC SMOOTH MUSCLE CELLS THROUGH DIFFERENT MECHANISMS
A. Orlandi, M. Marcellini, G. Di Biagio, L.G. Spagnoli, Rome, Italy

14:30 INCREASE RATE OF SPONTANEOUS CELL DEATH CHARACTERIZES THE VESSEL WALL STRUCTURAL CHANGES ASSOCIATED WITH EARLY CORONARY ATHEROSCLEROSIS IN PORCINE CORONARY ARTERIES
G. Sangiorgi, D. Hasdai, A. Mauriello, D.R. Holmes Jr., R.S. Schwartz, A. Lerman, L.G. Spagnoli, Rome, Italy

14:45 PERSISTENT ELEVATION OF sP-SELECTIN, TNF-a AND TNF-a RECEPTOR IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY EDEMA
P. Somasundaram, B.H. Sung, S.A. Mousa, M.F. Wilson, Buffalo NY, USA

15:00 STANDARDIZED B-MODE IMAGING OF CAROTID AND FEMORAL ARTERY WALLS PROVE INTIMA-MEDIA THICKNESS MEASUREMENTS AS VALID SURROGATE ENDPOINTS IN ATHEROSCLEROSIS STUDIES
E. de Groot, A. Wiegman, A.D.M. Swijndregt, A.F.W. van der Steen, R.J.G. Peters, R.G.A. Ackerstaff, J.J.P. Kastelein, A.V.G. Bruschke, Amsterdam, The Netherlands

15:15 MICROVASCULAR VASOCONSTRICTION DURING RESTING ISCHEMIA IN PATIENTS WITH UNSTABLE ANGINA
M. Marzilli, G. Sambuceti, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy

15:30 ANTIGEN-PRESENTING DENDRITIC CELLS ARE PRESENT IN AORTIC ATHEROSCLEROTIC LESIONS IN RATS WITH DIET-INDUCED HYPERCHOLESTEROLAEMIA
J. Ozmen, Y.V. Bobryshev, R.S.A. Lord, Sydney, Australia

15:45 C o f f e e B r e a k

MONDAY, MAY 17, 1999

PL05: Plenary Session
HYPERTENSION, BASIC AND CLINICAL
Chairpersons: W.H. Gaasch, Burlington MA, USA
                                I. Rubinstein, Chicago, IL, USA

16:00 HYPERTENSION - DISEASE OR SYMPTOM? A  NEW UNDERSTANDING FROM THE MOLECULAR VIEWPOINT (Invited Lecture)
R. Gasser, M. Brodmann, E. Kickenweiz, S. Barth, W. Klein, Graz, Austria

16:15 INTERRELATIONS BETWEEN STRUCTURE AND FUNCTION IN LARGE ARTERIES
(Invited Lecture)
C. Pitsavos, Athens, Greece

16:30 ULTRASONIC MYOCARDIAL TEXTURE AND HYPERINSULINEMIA IN ESSENTIAL HYPERTENSION
V. Di Bello, O. Giampietro, R. Pedrinelli, E. Matteucci, D. Giorgi, M.T. Caputo, A. Bertini, E. Boldrini, E. Talini, M. Paterni, C. Giusti, Pisa, Italy

16:45 RENOVASCULAR HYPERTENSION REDUCES b-ADRENERGIC MEDIATED CORONARY VASODILATION IN CONSCIOUS DOGSfs
G.P. Kline, M.A. Williams, P.A. Gwirtz, Fort Worth TX, USA

17:00 SYMPATHETIC ACTIVATION IN HYPERTENSION AND IN HEART FAILURE
(Invited Lecture)
G. Grassi, G. Mancia, Monza (Milan), Italy

17:15 THE HALLS HARBOUR SPONTANEOUSLY HYPERTENSIVE HAMSTER (4H): A NEW RODENT MODEL OF ESSENTIAL HYPERTENSION (Invited Lecture)
I. Rubinstein, Chicago IL, USA

17:30 SUBGROUP AND PER-PROTOCOL ANALYSIS OF THE RANDOMIZED EUROPEAN TRIAL ON ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY
J.A. Staessen, R. Fagard, L. Thijs, H. Celis, W.H. Birkenhager, C.J. Bulpitt, P.W. DeLeeuw, Leuven, Belgium

17:45 STATE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AT SUDDEN CARDIAC DEATH IN ESSENTIAL HYPERTENSIVE SUBJECTS WITH ALCOHOL INTOXICATION
V. Volkov, R. Sokolova, A. Vikhert, V. Zhdanov, Moscow, Russia

MONDAY, MAY 17, 1999

PL06: Plenary Session
ANTITHROMBOTIC AND ANTIPLATELET THERAPY FOR CORONARY DISEASE AND POOR VENTRICULAR FUNCTION
Chairpersons: M.D. Ezekowitz, New Haven CT, USA
                                J.E. Tcheng, Durham, NC, USA

16:00 ANTITHROMBOTIC THERAPY FOR LEFT VENTRICULAR DYSFUNCTION (Invited Lecture)
M.D. Ezekowitz, New Haven CT, USA

16:15 THE PLATELET GP IIb/IIIa INHIBITORS: WHY, WHEN, AND WHICH? (Invited Lecture)
J.E. Tcheng, Durham NC, USA

16:30 GP IIb/IIIa INHIBITORS IN ACUTE CORONARY SYNDROMES; WHAT HAVE WE LEARNED? (Invited Lecture)
P.C. Block, Portland OR, USA

16:45 THE RATIONALE OF MAGNESIUM AS ANTITHROMBOTIC TREATMENT FOR PATIENTS WITH CORONARY ARTERY DISEASE (Invited Lecture)
M. Shechter, Tel Hashomer, Israel

17:00 LOCAL DRUG DELIVERY ENHANCES ReoPro™ BINDING TO THE VESSEL WALL IN NON-HUMAN PRIMATES
B. Sundell, S. Verheye, K. Robinson, J. Cui, S. Ishiwata, D. Forestner, T. Pertile, N.A.F. Chronos, L.A. Harker, S.R. Hanson, Atlanta GA, USA

17:15 SAFETY AND EFFICACY OF CLOPIDOGREL COMPARED TO TICLOPIDINE FOR INTRACORONARY STENTING
N.E. Lepor, S.B. Gross, S.P. Luko, N.A. Buchbinder, Los Angeles CA, USA

17:30 EFFECT OF HEPARIN, TICLOPIDINE, AND AGGRASTAT ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE EX-VIVO ARTERIO-ARTERIAL SHUNT MODEL
Y. Zheng, S. Sukavaneshvar, F. Mohammad, K. Solen, Provo UT, USA

17:45 INFARCT ANGIOPLASTY: ABCIXIMAB AFTER RECENT THROMBOLYTIC THERAPY IS SAFE
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

MONDAY, MAY 17, 1999

S76: NEW FRONTIERS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: B. Pieske, Gottingen, Germany
                                U. Thadani, Oklahoma City, OK, USA

16:00 SAFETY STUDY OF NESIRITIDE (HUMAN B-TYPE NATRIURETIC PEPTIDE) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH ACUTELY DECOMPENSATED CHF
U. Elkayam, M. Neibaur, H. Haught, D.P. Horton, Los Angeles CA, USA

16:15 EFFECT OF NESIRITIDE VERSUS DOBUTAMINE FOR TREATMENT OF ACUTELY DECOMPENSATED HEART FAILURE ON CARDIOVASCULAR ADVERSE EVENTS
A.J. Burger, A. Johnson, D. Horton, Boston MA, USA

16:30 INTERACTION BETWEEN SOLUBLE AND PARTICULATE GUANYLATE CYCLASES ON PULMONARY RESISTANCE VESSELS IN VIVO: THE ROLE OF ANP
H. Lippton, A. Hyman, New Orleans LA, USA

16:45 COMBINED ANGIOTENSIN II AND ENDOTHELIN-1 RECEPTOR BLOCKADE IN HEART FAILURE: EFFECT ON EXERCISE PERFORMANCE
C-P. Cheng, Winston-Salem NC, USA

17:00 RELEVANCE OF VENTRICULAR REMODELING TO CHANGES IN EXERCISE CAPACITY IN PATIENTS WITH CHRONIC HEART FAILURE
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, D.G. Gibson, A.J.S. Coats, London, UK

17:15 INACTIVATION OF RENIN ANGIOTENSIN SYSTEM IN TISSUE PREVENTS EXCESS HYPERTROPHY CONTRIBUTING TO TRANSITION TO HEART FAILURE
Y. Sakata, T. Masuyama, K. Yamamoto, T. Kondo, H. Mano, R. Doi, K. Ono, T. Kuzuya, M. Hori, Suita, Japan

17:30 LOSARTAN PREVENTS CONTRACTILE DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION IN RATS
M.C.G. Daniels, R.S. Keller, P.P. de Tombe, Ben Bosch, The Netherlands

MONDAY, MAY 17, 1999

S54: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH II
Chairpersons: H.M. Hoffmeister, Tubingen, Germany
                                P.K. Singal, Winnipeg, Canada

16:00 LDL STIMULATES MKP-1 EXPRESSION INDEPENDENT OF LDL RECEPTORS IN VASCULAR SMOOTH MUSCLE CELLS
B. Metzler, C. Li, Y. Hu, Q. Xu, Innsbruck, Austria

16:15 INHIBITION OF RESTENOSIS BY ALDOSE REDUCTASE ANTAGONISM
J. Ruef, T.K. Nordt, C. Bode, C. Patterson, Heidelberg, Germany

16:30 ANGIOGRAPHICALLY NORMAL INTERNAL MAMMARY ARTERIES SHOW NEOINTIMA FORMATION IN LATE-STATE CHD
N. Al-Fakhri, B. Huang, M. Heidt, B. Hinrichs, F.W. Hehrlein, N. Katz, Giessen, Germany

16:45 LOCAL OR SYSTEMIC DELIVERY OF AN ANTISENCE INHIBITS C-MYC EXPRESSION FOLLOWING BALLOON ANGIOPLASTY
P. Iverson, V. Skrinska, E. Keane, D. Stein, D. Weller, P. Chawla, A. Tamarkin, N.N. Kipshidze, Milwaukee WI, USA

17:00 INHIBITION OF PLATELET FUNCTION BY PURPLE GRAPE JUICE IN VITRO AND IN VIVO
J. Freedman, L. Deak, R. Sauter, J.D. Folts, C. Parker, Washington DC, USA

17:15 EFFECT OF CORONARY ANGIOPLASTY ON CORONARY MICROVASCULAR RESPONSE TO TACHYCARDIA
G. Sambuceti, M. Marzilli, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy

17:30 CHARACTERIZATION OF THE CARDIOVASCULAR SYSTEM IN A NEW EXPERIMENTAL MODEL OF STRESS-SENSITIVE ARTERIAL HYPERTENSION (ISIAH RAT STRAIN)
N.A. Machanova, A.L. Markel, Novosibirsk, Russia

MONDAY, MAY 17, 1999

SAT: Satellite Symposium
ATHEROSCLEROSIS UPDATE: CAUSES, CONSEQUENCES AND CLINICAL MANAGEMENT OF CORONARY DISEASE
This Symposium is sponsored by the Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine
This Symposium is made possible in part by an unrestricted educational grant from Pfizer Inc.

Chairperson: M. Bodenheimer, New Hyde Park NY, USA

19:30 INTRODUCTION
M. Bodenheimer, New Hyde Park NY, USA

19:35 THE AGING HEART: CURRENT CONCEPTS AND CLINICAL COROLLARIES IN PATIENTS WITH CORONARY DISEASE
C.M. O'Connor, Durham NC, USA

20:00 TRADITIONAL AND NEWER IMAGING TECHNIQUES IN THE EVALUATION OF CORONARY DISEASE AND ITS TREATMENT
S. Nissen, Cleveland OH, USA

20:25 NEW DIRECTIONS IN THE MANAGEMENT OF ATHEROSCLEROSIS: CLINICAL TRIAL UPDATE
B. Pitt, Ann Arbor MI, USA

20:50 NEW MECHANISMS OF CYTOPROTECTION IN CARDIOVASCULAR DISEASE
R.P. Mason, Pittsburgh PA, USA

21:15 Discussion

21:25 CONCLUDING REMARKS
M. Bodenheimer, New Hyde Park NY, USA

MONDAY, MAY 17, 1999

P101: Poster Session
MOLECULAR CARDIOLOGY, BASIC RESEARCH

Board No.

1. DIFFERENTIAL EXPRESSION PATTERNS OF CARDIAC PROTEIN KINASE C ISOFORMS IN SEVERE DILATED CARDIOMYOPATHY AND IN AORTIC STENOSIS - A PIVOTAL ROLE FOR PKC-b?
S.K. Briem, S. Lichte, R. Lange, S. Hagl, W. Kuebler, R.H. Strasser, Heidelberg, Germany

2. ANTIISCHEMIA DRUG PREDUCTAL AS SELECTIVE, ACTIVATOR OF Cu,Zn-SUPEROXIDE DISMUTASE
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia

3. A NEW METHOD FOR SUCCESSFUL CULTURE OF HUMAN CARDIOMYOCYTES
K. Macfelda, T. Wild, S.C. Beutelspacher, A.M. Groeger, B. Kapella, U. Losert, E. Wolner, R. Seitelberger, Vienna, Austria

4. ENDOTHELIN INTERACTS WITH ADENYLATE CYCLES AND MODIFIES ELECTROPHYSIOLOGICAL EFFECTS OF ISOPROTERENOL ON ISOLATED CANINE VENTRICULAR MYOCYTES
A. Mohacsi, J. Magyar, T. Banyasz, P. Nanasi, Debrecen, Hungary

5. THE MORPHOLOGIC CHARACTERISTICS OF CARDIAC MYOCYTES AND COLLAGEN MATRIX IN PATIENTS WITH END-STAGE HEART FAILURE
J.J. Shyu, S.H. Chu, S.S. Wang, N.K. Chou, S.K. Liu, Taipei, Taiwan-R.O.C.

6. ANGIOTENSIN-CONVERTING ENZYME GENE INSERTION/DELETION POLYMORPHISM AND OBSTRUCTIVE SLEEP APNEA
J. Zhang, R. Hui, Gesangluobu, M. Xu, J. Ye, W. Pei, Y. Sun, B. Liu, L. Liu, Beijing, China

 

MONDAY, MAY 17, 1999

P109: Poster Session
NUCLEAR CARDIOLOGY

Board No.

7. NON INVASIVE ESTIMATION OF INVASIVE TREATMENT RESULTS OF PATIENTS WITH CORONARY ARTERY STENOSIS
B. Birkenfeld, E. Plonska, R. Gil, J. Goracy, E. Slovinska, M. Puchala, A. Wojtarowicz, Szczecin, Poland

8. DETECTION OF VIABLE MYOCARDIUM: A STUDY OF PERFUSION, BEFORE AND AFTER SURGICAL REVASCULARIZTION, IN SUBJECTS WITH PREVIOUS MYOCARDIAL INFARCT
W.A. Chalela, P.J. Moffa, J.F. Ramires, A.P. Moraes, J. Soares Jr., C. Meneghetti, Sao Paulo, Brazil

MONDAY, MAY 17, 1999

P109: Poster Session
NUCLEAR CARDIOLOGY (cont)

Board No.

9. DUAL ISOTOPES (TI-201 AND I-123-BMIPP) SPECT STUDIES IN DETECTING MYOCARDIAL SALVAGE EFFECTS OF ACUTE MYOCARDIAL INFARCTION WITH VARIOUS REPERFUSION THERAPIES
T. Furuta, T. Kondo, M. Sarai, A. Matsuba, S. Motoyama, M. Tokuda, H. Yokoi, Y. Abo, Y. Watanabe, Nagoya, Japan

10. PROGNOSTIC VALUE OF THE MYOCARDIUM PERFUSION STUDIES WITH 99Tcm-SESTAMIBI SPECT
F.G. Gallego, J. Pereira, J. Perea, P. Robles, D. Hernandez, Madrid, Spain

11. COMPARISON OF RADIONUCLIDE ANGIOGRAPHY AND TWO - DIMENSIONAL ECHOCARDIOGRAPHY WITH CONTRAST ANGIOGRAPHY IN DETECTION OF VENTRICULAR ANEURYSM
C.T. Ginghina, E. Apetrei, G. Jovin, B. Fotiade, I. Ene, I. Kulcsar, D. Qeshta, Bucharest, Romania

12. EFFECT OF CHAMBER SIZE ON ACCURACY OF DUAL ISOTOPE MYOCARDIAL PERFUSION SPECT
E.Y. Kimchi, X. Kang, H.C. Lewin, J.D. Friedman, G. Germano, R. Hachamovitch, D.S. Berman, Los Angeles CA, USA

13. VISUALIZATION OF SUBENDOCARDIAL ISCHEMIA / INFARCTION BY SERIAL ECG-GATED DUAL (TE-99m-TETROFOSMIN (Tf) MYOCARDIAL AND Tc-99mm-HSAD CARDIAC POOL) SPECT
T. Kondo, M. Sarai, J. Wang, M. Tokuda, S. Motoyama, A. Matsuba, H. Shinozaki, E. Ishikawa, K. Ohshima, Y. Nakamura, T. Furuta, J. Ishii, H. Kurokawa, H. Naruse, Y. Watanabe, S. Tachiki, Toyoake, Japan

14. COMPARISON OF THE CK-MB LEVEL AFTER CABG WITH Tc-99m-MIBI SPECT AND RADIONUCLIDE VENTRICULOGRAPHY IN PREDICTING THE EFFICACY OF REVASCULARISATION
P. Kwinecki, A. Baszko, M. Jemielity, P. Buczkowski, K. Blaszyk, M. Ruchala, A. Cieslinski, A. Ponizynski, J. Sowinski, Poznan, Poland

15. THE VALIDATION OF RISK AREA ASSESSMENT BY ECG AT HOSPITAL ARRIVAL OBTAINED BEFORE REPERFUSION THERAPY IN ACUTE MYOCARDIAL INFARCTION. -COMPARISON WITH SCINTIGRAPHICAL AREA AT RISK
K. Watanabe, H. Matsuo, K. Sano, K. Suzuki, Y. Hashimoto, I. Murata, K. Hayakawa, S. Tanihata, T. Matsubara, Y. Matsuno, S. Watanabe, Gifu, Japan

MONDAY, MAY 17, 1999

P117: Poster Session
LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION

Board No.

16. EXERCISE INDUCED QRS PROLONGATION IS A PREDICTOR OF POSTINFARCTION REMODELING
K.G. Adamian, A.L. Chilingarian, A.V. Astvatsatrian, A.Z. Garibgeanian, Yerevan, Armenia

17. EFFECTS OF REVASCULARIZATIONOF TOTALLY OCCLUDED CORONARY ARTERIES ON LEFT VENTRICULAR PERFORMANCE IN PATIENTS AFTER MYOCARDIAL INFARCTION
S. Ozgul, Kahramanmaras, Turkey

18. DECREASED SENSITIVITY TO b-ADRENERGIC STIMULATION OF VENTRICULAR L-TYPE CALCIUM CURRENT IN INFARCT-INDUCED HYPERTROPHY IN RATS
R.M. Saraiva, M.O. Masuda, Rio de Janeiro, Brazil

19. CHRONIC HEART FAILURE IN REMODELING AFTER MYOCARDIAL INFARCTION: SELECTIVE REGULATION OF THE ISOZYMES OF PROTEIN KINASE C
G. Simonis, J. Honold, C. Weinbrenner, U. Oehl, R.H. Strasser, Heidelberg, Germany

 

MONDAY, MAY 17, 1999

P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION

Board No.

20. EPIDEMIOLOGICAL STUDY OF HYPERTENSION IN FOUR MOSCOW SUBURBAN TOWNS. RESULTS OF DEMOGRAPHY, SOCIAL AND MEDICAL SCREENING OF 1998
A. Britov, A. Deev, S. Shalnova, N. Eliseeva, R. Oganov, Moscow, Russia

21. THE IMPACT OF SILENT ISCHEMIA ON CARDIAC ENZYMES AND WALL MOTION IN PATIENTS UNDERGOING AEROBIC EXERCISE
D. Dobies, K. Tobin, H. Friedman, P. Marcovitz, M. Pica, W. O'Neill, B. Franklin, Royal Oak MI, USA

22. DOES LOW FLUID INTAKE INCREASE THE RISK OF STROKE? FINDINGS FROM THE ADVENTIST HEALTH STUDY
S.F. Knutsen, J. Chan, Loma Linda CA, USA

23. DETERMINANTS OF THE AMOUNT OF AUTONOMIC RESPONSE TO REHABILITATION AFTER MYOCARDIAL INFARCTION
G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy

24. QUALITY OF LIFE IMPROVEMENT AFTER MYOCARDIAL REVASCULARISATION
B. Mihajlovic, M. Potic, Z. Potic, M. Popov, Z. Konstantinovic, S. Popovic, D. Jakovljevic, N. Radovanovic, Novi Sad, Yugoslavia

MONDAY, MAY 17, 1999

P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION (cont)

Board No.

25. PROGNOSTIC FACTORS OF RECURRENT MYOCARDIAL INFARCTION
R. Radisauskas, Kaunas, Lithuania

26. TIME TRENDS OF THE HEALTH PROFILE AND MORTALITY IN THE MALE POPULATION OF TALLINN, ESTONIA
O. Volozh, A. Deev, T. Kalyuste, R. Kaup, E. solodkaya, J. Abina, G. Goldsteine, A. Olferiev, Tallinn, Estonia

 

MONDAY, MAY 17, 1999

P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE

Board No.

27. IS MILD HYPERCHOLESTEROLEMIA WITHOUT MULTIPLE RISK FACTORS BENIGN IN YOUNG ADULTS? THE GUNDERSEN PREMATURE CORONARY DISEASE REVIEW
K.O. Akosah, B. Gower, La Crosse WI, USA

28. LOWER INCIDENCE OF CORONARY DISEASE IN PUERTO RICO (USA ISLAND) THAN IN THE CONTINENTAL USA: A POSSIBLE PROTECTIVE EFFECT OF A LOWER LDL/HDL LIPOPROTEIN RATIO
P.I. Altieri, E. Rodriguez, N. Escobales, R. Gonzalez, H. Banch, M.J. Crespo, J. Rodriguez, San Juan, Puerto Rico

29. SHORT-TERM TREATMENT WITH HIGH-DOSE SIMVASTATIN IMPROVES WIDESPREAD VASCULAR PERMEABILITY IN SUBJECTS WITH OVERT ATHEROSCLEROTIC DISEASE
S. Bandinelli, G. dell'Omo, L. Pucci, M. Mariani, R. Navalesi, R. Pedrinelli, G. Penno, Pisa, Italy

30. SAFETY AND EFFICACY OF FIBRATES IN DIABETIC AND NON-DIABETIC PATIENTS WITH REFRACTORY COMBINED HYPERLIPIDEMIA
M. Kayikcioglu, F. Ozerkan, O. Yavuzgil, M. Zoghi, C. Gurgun, H. Kultursay, L. Can, C. Turkoglu, Izmir, Turkey

31. PURPLE GRAPE JUICE PROTECTS LDL FROM OXIDATION IN CORONARY ARTERY DISEASE PATIENTS TAKING VITAMIN E
J.G. Keevil, D. Wiebe, J.D. Folts, Madison WI, USA

32. CORRELATION OF LIPOPROTEIN(A), HOMOCYSTEINE AND MYOCARDIAL STRESS THALLIUM SCINTIGRAPHY IN CHD PATIENTS
G. Lupattelli, B. Palumbo, D. Siepi, C. Casciari, P.F. Anniboletti, A. Bianchi, L. Pasqualini, G. Schillaci, R. Palumbo, E. Mannarino, Perugia, Italy

MONDAY, MAY 17, 1999

P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE (cont)

Board No.

33. ORALLY APPLIED ENTEROCOCCUS FAECIUM M-74 IN PREVENTIVE CARDIOLOGY
Z. Mikes, M. Ferencik, L. Ebringer, E. Jahnova, I. Ciznar, Bratislava, Slovak Republic

34. PREVALENCE OF DYSLIPIDEMIA DURING IN-HOSPITAL PHASE OF THE ACUTE CORONARY SYNDROMES
L.C.S. Passos, R. Santos-Jesus, D. Flores, U. Costa, N. Lobo, A. Rabelo Jr., Salvador, Brazil

 

MONDAY, MAY 17, 1999

P126: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSIS

Board No.

35. WEIGHT LOSS, WEIGHT MAINTENANCE AND IMPROVEMENT IN CARDIOVASCULAR RISK AFTER 2 YEARS OF ORLISTAT THERAPY
A.E. Meinders, Leiden, The Netherlands

36. BODY HABITUS IN ACUTE HEART FAILURE PATIENTS: OBESITY PREDICTS IMPROVED OUTCOMES
D. Milzman, R. Samaddar, K. Samaddar, J. Morissey, L. Moscowitz, Washington DC, USA

37. DIABETES MELLITUS - AN INCREASED RISK FACTOR FOR ISCHEMIC HEART DISEASE IN FEMALE?
M. Monteiro, A. Felix, V. Mendes, C. Barradas, A. Sousa, I. Joao, J. Sa Nogueira, A. Aleixo, A. Sales Luis, Lisbon, Portugal

38. RELATION OF HEART RATE VARIABILITY AND LEFT VENTRICLE DIASTOLIC FUNCTION TO SILENT ISCHEMIA DURING 24 HOUR AMBULATORY ECG IN PATIENT WITH NON-INSULIN DEPENDENT DIABETES MELLITUS
A. Mrochek, D. Goncharik, Minsk, Belarus

 

MONDAY, MAY 17, 1999

P129: Poster Session
HORMONE THERAPY IN POSTMENOPAUSAL WOMEN

Board No.

39. TIBOLONE EFFECT ON BLOOD PRESSURE AND PLASMA LIPIDS IN HYPERTENSIVE WOMEN
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Wierzbicki, G. Jackson, London, UK

40. CORONARY ARTERY LESIONS AND LEFT VENTRICULAR FUNCTION IN FEMALE PATIENTS WITH CORONARY ARTERY DISEASE
S. Ozgul, Kahramanmaras, Turkey

MONDAY, MAY 17, 1999

P130: Poster Session
CARDIAC INVOLVEMENT IN HIV INFECTION

Board No.

41. DIASTOLIC DYSFUNCTION IS AN EARLY MARKER OF CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, M. Pombo, R. Dalmau, C.S. de la Calzada, Madrid, Spain

42. ECHOCARDIOGRAPHY DETECTS IMMUNE-RELATED ASYMPTOMATIC CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, P. Hernandez, R. Gascuena, M. Lazaro, C.S. de la Calzada, Madrid, Spain

 

MONDAY, MAY 17, 1999

P131: Poster Session
NITRIC OXIDE AND NITRIC OXIDE SYNTHASE IN HEART FAILURE

Board No.

43. NO DOES NOT MEDIATE CORONARY VASODILATION SECONDARY TO SIMULATED ISCHEMIA: A STUDY ON K_ATP -CHANNELS AND N^W -NITRO-1-ARGININ ON CORONARY PERFUSION PRESSURE IN ISOLATED LANGENDORFF-PERFUSED GUINEA PIG HEARTS
E. Kickenweiz, M. Brodmann, R. Gasser, H. Brussee, W. Klein, Graz, Austria

 

MONDAY, MAY 17, 1999

P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL CORONARY ARTERY DISEASE

Board No.

44. SURGICAL REVASCULARIZATION OF POSTERIOR CORONARY ARTERIES WITHOUT CARDIOPULMONARY BYPASS
J.G. Lobo Filho, J.M.A.C. de Albuquerque, C. Bellini, G. Gomes, M.C. Letiao, E.B. Pinheiro, J.N. Paes Jr., R.P. de Siqueira, M.M. Landim, R.R.M. Oliveira, Fortaleza, Brazil

45. OUTCOMES IN A RANDOMIZED COMPARISON OF MINIMALLY INVASIVE CABG WITH CONVENTIONAL CABG AND PTCA STENT; THE OCTOPUS STUDY
E. Buskens, Utrecht, The Netherlands

46. LONG TERM SURVIVAL IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING: IMPACT OF ARTERIAL REVASCULARIZATION
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France

MONDAY, MAY 17, 1999

P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE (cont)

Board No.

47. PREDICTORS OF LONG TERM SURVIVAL AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS UNDER 65 YEARS
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France

48. HYBRID REVASCULARIZATION: MINIMALLY INVASIVE SURGERY PLUS ANGIOPLASTY, INITIAL RESULTS IN 16 PATIENTS
R. Gascuena, A. Albarran, F. Hernandez, E. Rodriquez, M.J. Lopez, J. Tascon, J. Andreu, M. Alonso, M. Lazaro, P. Hernandez, Madrid, Spain

49. CORONARY ARTERY SURGERY WITHOUT CARDIOPULMONARY BYPASS IN PATIENTS OVER 80 YEARS OF AGE
G. Lobo Filho, C.B.G. Gomes, J.M.A.C. de Albuquerque, A. Feitosa, M.C. Leitao, E.B. Pinheiro, J.N. Paes Junior, R.M. Landim, R.P. de Siqueira, R.M. Oliveira, Fortaleza, Brazil

50. SURGICAL TREATMENT OF DIFFUSE AND DISTAL CORONARY ARTERY DISEASE - EXPERIENCE IN OVER 3,000 OPERATED PATIENTS
N. Radovanovic, L. Petrovic, S. Nicin, J. Selestiansky, Z. Jonjev, J. Lavac, M. Fabri, P. Kovacevic, M. Mijatov, V. Scekic, S. Popovic, Z. Konstantinovic, M. Preradovic, Novi Sad, Yugoslavia

 

MONDAY, MAY 17, 1999

P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT

Board No.

51. IMMEDIATE AND LONG TERM OUTCOME AFTER AORTIC VALVE REPLACEMENT AMONG PATIENTS WITH SEVERE AORTIC STENOSIS AND LEFT VENTRICULAR SYSTOLIC DYSFUNCTION PHILIPPINE HEART CENTER EXPERIENCE
A.M.L.A. Delos Reyes-Javier, P. Palmes, S.M. Lacson, R.D. Jara, R.J. Santos, A. Rico, Manila, Philippines

52. THE VALUE OF CARDIAC TROPONIN IN THE DIAGNOSIS OF RHEUMATIC FEVER
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E.S. del Fuerte, Manila, Philippines

53. AIRWAY FUNCTION DISTURBANCES AFTER SUCCESSFUL CORRECTION OF A MITRAL VALVE DISEASE. LONG TERM FOLLOW UP
T. Hryniewiecki, I. Rawczynska-Englert, R. Malinowski, P. Gutkowski, Warsaw, Poland

MONDAY, MAY 17, 1999

P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont0

Board No.

54. SURGICAL OUTCOME AND LONG-TERM RESULTS AFTER AORTIC VALVE REPLACEMENT IN OCTOGENARIANS
P. Kolh, L. Lahaye, P. Gerard, R. Limet, Liege, Belgium

55. EFFECTIVE MITRAL REGURGITANT ORIFICE AREA. COMPARISON OF THREE ECHOCARDIOGRAPHIC METHODS
C.S. Berensztein, D.J. Pineiro, M.M. Marcotegui, R.L. Brunoldi, G. Lanosa, J. Lerman, Buenos Aires, Argentina

56. EVOLUTION OF AORTIC REGURGITATION AFTER PERCUTANEOUS BALLOON MITRAL VALVULOTOMY
A. Popa, E. Apetrei, C. Ginghina, M. Iacob, I. Coman, C. Carp, Bucharest, Romania

57. LEFT ATRIAL KINETIC ENERGY IN NORMAL SUBJECTS AND IN PATIENTS WITH MITRAL STENOSIS
S. Qirko, T. Goda, A. Dibra, Tirana, Albania

 

MONDAY, MAY 17, 1999

P154: Poster Session
PRACTICE GUIDELINES, COST CONTAINMENT

Board No.

58. ANALYSIS AND COMPARISON OF CORONARY CARE UNIT COST PROCESS IN TWO CONSECUTIVE YEARS
J.A. Gomez, I. Roldan, I.G. Maqueda, J. Perea, A. Sanchez, E.R. Armada, H. Navarro, L.M. Jadraque, H. La Paz, Madrid, Spain

59. CARDIO-RESPIRATORY PATTERNS OF THE OBESE SUBJECT DURING EXERCISE IN THE PERSPECTIVE OF A TRAINING PROGRAM
A. Salvadori, P. Fanari, F. Nibbio, A. Saezza, E. Longhini, Verbania, Italy

60. FEASIBILITY AND SAFETY OF EARLY EXERCISE TESTING USING THE BRUCE PROTOCOL AFTER ACUTE MYOCARDIAL INFARCTION
M.P. Senaratne, G.A. Smith, Edmonton, Alberta, Canada

61. MANAGEMENT OF 1700 HYPERTENSIVE DIABETIC OUTPATIENTS AND GUIDELINES USE IN GENERAL PRACTICE
A. Zaninelli, A. Filippi, Florence, Italy

MONDAY, MAY 17, 1999

P156: Poster Session
MISCELLANEOUS

Board No.

62. GRAPE SEED PROCYANIDINS: ISOLATION, IDENTIFICATION, AND ENDOTHELIUM-DEPENDENT VASORELAXING ACTIVITY
D.F. Fitzpatrick, B. Bing, D. Maggi, D. Fries, R. O'Malley, Tampa FL, USA

63. ECHOCARDIOGRAPHY BEFORE AND AFTER PERICARDIECTOMY IN PATIENTS WITH CONSTRICTIVE PERICARDITIS - COULD BE ONLY ONE METHOD TO EXPLORE?
C.T. Ginghina, E. Apetrei, I. Stoian, I. Kulcsar, D. Qeshta, I. Ene, C. Matei, Bucharest, Romania

64. GRAVITATIONAL STRESS (GS) IN SYSTEMIC SCLEROSIS (SS)
E.S. Isasi, A. Cassinelli, R. Vignale, M.E. Isasi, Montevideo, Uruguay

65. CARDIAC INVOLVEMENT IN ANTIPHOSPHOLIPID SYNDROME
I. Moyssakis, M. Tektonidou, K. Boki, F. Triposkiadis, M. Gofa, M. Kyriakidis, Athens, Greece

66. CHANGES OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
I. Moyssakis, F. Triposkiadis, V. Vasiliou, M. Gofa, G. Anastasiadis, M. Kyriakidis, Athens, Greece

67. ABNORMAL SYSTOLIC BLOOD PRESSURE RESPONSE IN THE RECOVERY PHASE OF EXERCISE TESTING AS A PREDICTOR OF CORONARY ARTERY DISEASE
A. Zarife, E. Camara, F. Galvao, L. Viana, O. Marques, W. Freitas, C. Macedo, M. Santos, M. Guimaraes, A. Rabelo Jr., Salvador, Brazil

  TUESDAY, MAY 18, 1999

PL07: Plenary Session
NEW INSIGHTS INTO THE MECHANISMS OF HEART FAILURE
Chairpersons: W.C. Little, Winston-Salem NC, USA
                            H.N. Sabbah, Detroit MI, USA

08:30 DIASTOLIC DYSFUNCTION: CONTRIBUTION TO EXERCISE INTOLERANCE
(Invited Lecture)
W. Little, Winston-Salem NC, USA

08:45 INHIBITION OF DOPAMINE BETA-HYDROXYLASE AS A THERAPEUTIC TARGET IN THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah, S. Goldstein, Detroit MI, USA

09:00 ALTERED EXCITATION-CONTRACTION COUPLING IN HEART FAILURE (Invited Lecture)
G. Hasenfuss, B. Pieske, J. Prestle, Freiburg, Germany

09:15 APOPTOSIS AND CARDIAC DISEASES - NEW OPPORTUNITIES FOR NOVEL THERAPEUTICS (Invited Lecture)
G.Z. Feuerstein, Wilmington DE, USA

09:30 AGONIST STIMULATED NITRIC OXIDE PRODUCTION AND MYOCARDIAL CONTRACTILITY (Invited Lecture)
J.M. Hare, Baltimore MD, USA

09:45 CLINICAL USE OF INHALED NITRIC OXIDE IN ADULT CARDIAC SURGICAL PATIENTS (Invited Lecture)
K.J. Ramsay, M.A.E. Ramsay, K. Lynch, H.A.T. Hein, D.M. Meyer, Dallas TX, USA

10:00 OXIDATIVE STRESS AND HEART FAILURE: ROLE OF VITAMIN A (Invited Lecture)
V. Palace, M. Hill, I. Danelisen, P.K. Singal, Manitoba, Winnipeg, Canada

10:15 BASIC ASPECTS OF HEART FAILURE: HUMAN MYOCARDIUM (Invited Lecture)
C.J.F. Holubarsch, Freiburg, Germany

10:30 SARCOPLASMIC RETICULUM FUNCTION IN HEART FAILURE
P. Neary, A.M. Duncan, G.L. Smith, S.M. Cobbe, Glasgow, UK

10:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL08: Plenary Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE
Chairpersons:       C. Rosendorff, New York NY, USA
                                Y. Stein, Jerusalem, Israel

08:30 REVERSE CHOLESTEROL TRANSPORT - A NEW METHOD FOR QUANTITATIVE ASSESSMENT OF CHOLESTEROL EFFLUX IN VIVO (Invited Lecture)
Y. Stein, O. Stein, Jerusalem, Israel

08:45 LDL CHOLESTEROL AND VASCULAR STRUCTURE AND FUNCTION (Invited Lecture)
C. Rosendorff, New York NY, USA

09:00 NON-HDLC DOES NOT REFLECT THE PRESENCE OF SMALL LDL PATTERN B
(Invited Lecture)
H.R. Superko, R.M. Krauss, San Mateo CA, USA

09:15 TISSUE O₂ AVAILABILITY IS A FUNCTION OF THE PLASMA CHOLESTEROL (Invited Lecture)
H. Buchwald, H.J. Menchaca, V.N. Michalek, B.A.T.D. Rohde, T.J. O'Dea, Minnesota MN, USA

09:30 THE INFLUENCE OF LIPIDS ON THE INCIDENCE OF THROMBOCYTOSIS FOLLOWING MYOCARDIAL REVASCULARIZATION
J.T. Christenson, Geneva, Switzerland

09:45 AN IN VITRO STUDY ON THE ANTIOXIDANT CAPACITY OF STATINS
F. Franzoni, F. Regoli, F. Galetta, Pisa, Italy

10:00 EFFECTS OF ATORVASTATIN ON PLASMA HOMOCYSTEINE LEVELS IN SUBJECTS WITH FAMILIAL HYPERCOLESTEROLEMIA
L. Pucci, S. Bandinelli, G. Penno, M. Pilo, R. Navalesi, A. Bertolotto, Pisa, Italy

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S77: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE
Chairperson: M. Hauser, Munich, Germany

08:30 CORONARY FLOW RESERVE ASSESSED BY POSITRON EMISSION TOMOGRAPHY (PET) IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES (TGA) AFTER ANATOMICAL CORRECTION
M. Hauser, A. Kuhn, M. Beckmann, F. Bengel, M. Schwaiger, J. Hess, Munich, Germany

08:45 CATHETER CLOSURE OF INTER-ATRIAL DEFECTS IN ADULTS WITH SELF-CENTERING DEVICES
H. Sievert, U. Krumsdorf, P. Keppeler, S. Rux, R. Schrader, A. Fach, D. Scherer, R. Ensslen, H. Merle, H. Spies, H. Zeplin, Frankfurt, Germany

09:00 PSYCHOPATHOLOGY IN YOUNG ADULTS WITH CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, H.J.M. Versluis, F.C. Verhulst, F.J. Meijboom, E. Bos, J.R.T.C. Roelandt, J. Hess, Rotterdam, The Netherlands

09:15 PULMONARY ARTERY SLING: REIMPLANTATION VERSUS ANTETRACHEAL TRANSLOCATION
J.A.M. van Son, G.S. Haas, H. Hess, J. Hambsch, P. Schneider, F.W. Mohr, Tampa, USA

09:30 STENT IMPLANTATION FOR THE TREATMENT OF EARLY POSTOPERATIVE THROMBOSIS OF MODIFIED BLALOCK-TAUSSIG-SHUNTS
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany

09:45 PREDISPOSING FACTORS OF VALVE REGURGITATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S. Mimori, T. Kikuchi, Y. Takahashi, Y. Murakami, Tokyo, Japan

10:00 THE RESULTS OF THE REPAIR OF ATRIAL SEPTAL DEFECT WITH OR WITHOUT PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION IN PATIENTS OVER 40 YEARS OLD. ECHOCARDIOGRAPHIC AND CLINICAL STUDY
L. Paluszkiewicz, M. Jemielity, B. Perek, P. Buczkowski, A. Szyszka, W. Dyszkiewicz, A. Ponizynski, Poznan, Poland

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S78: ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY- BASIC AND CLINICAL
Chairpersons:        J. Jalife, Syracuse NY, USA
                                S. Schaefer, Davis CA, USA

08:30 QUANTITATIVE COMPARISON OF ATRIAL FIBRILLATION AND VENTRICULAR FIBRILLATION IN THE SAME ANIMALS
G.L. Pierpont, C.C. Gornick, J.A. Hauck, B.D. Pederson, J.J. Alwin, J.M. Weigenant, Minneapolis MN, USA

08:45 CHANGES OF AUTONOMIC NERVOUS SYSTEM ACTIVITY IN UREMIC PATIENTS ON HEMODIALYSIS
F. Franzoni, A. Cupisti, A. Caprioli, C. Giusti, G. Barsotti, F. Galetta, Pisa, Italy

09:00 OUABAIN PROMOTES DELAYED AFTERDEPOLARIZATION DEPENDENT TRIGGERED ACTIVITY IN THE HYPETROPHIED BUT NOT IN THE NON-HYPERTROPHIED CANINE HEART
M. De Groot, M. Vos, J. Leunissen, M. Schoenmakers, H.J.J. Wellens, Maastricht, The Netherlands

09:15 RADIOFREQUENCY CATHETER ABLATION OF CENTRAL SUPERHIGH WAY OF ATRIAL CONDUCTION IS EFFECTIVE IN TERMINATING SUSTAINED ATRIAL FIBRILLATION IN DOGS
D. Hu, T. Liu, X. Yang, C. Guo, Beijing, China

09:30 IMPLANTATION OF PERMANENT PACEMAKERS GUIDED BY TRANSTHORACIC ECHOCARDIOGRAPHY
G. Diaz, P. Pacheco, H. Acuna, A. Diaz, Chiclayo, Peru

09:45 INTRACARDIAC ECHOCARDIOGRAPHIC EVALUATION OF RADIOFREQUENCY LESION EFFECTS IN ATRIAL AND VENTRICULAR MYOCARDIUM
J.-F. Ren, D.J. Callans, D. Schwartzman, J.J. Michele, K.S. Li, F.E. Marchlinski, Pittsburgh PA, USA

10:00 NEW-ONSET ATRIAL FIBRILLATION IN Q WAVE ANTERIOR MYOCARDIAL INFARCTION; PROGNOSTIC SIGNIFICANCE OF RECURRENCES OF ATRIAL FIBRILLATION
M. Asanin, J. Perunicic, V. Vukcevic, A. Arandjelovic, D. Orlic, P. Mitrovic, B. Sreckovic, M. Nesovic, M. Matic, Z. Vasiljevic, D. Boskovic, Belgrade, Yugoslavia

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S73: ECHOCARDIOGRAPHY, PHARMACOLOGIC STRESS TESTING
Chairpersons:        J. Ge, Essen, Germany
                                 F.J. Pinto, Lisboa, Portugal

08:30 MULTICENTER VIDEODENSITOMETRIC ASSESSMENT OF EFFECTS OF BIOLOGICAL FACTORS ON EFFICACY OF OPTISON™ AND ALBUNEX® IN DIFFICULT-TO-IMAGE PATIENTS
E. Hausnerova, J.S. Gottdiener, D.E. Bruns, H. Dittrich, J.L. Cohen, J.C. Pezzullo, Washington DC, USA

08:45 DETERIORATION OF MYOCARDIAL FUNCTION DURING DOBUTAMINE ECHOCARDIOGRAPHY DOES NOT EXCLUDE IMPROVEMENT AFTER SURGICAL REVASCULARIZATION
L. Paluszkiewicz, M. Jemielity, A. Szyszka, A. Baszko, A. Cieslinski, Poznan, Poland

09:00 EXERCISE ECHOCARDIOGRAPHY: ITS ACCURACY AND VALUE IN THE PROGNOSIS OF PATIENTS WITH KNOWN OR SUSPECTED CORONARY ARTERY DISEASE (CAD)
J.T. Baltasar, O.P. Saniel, E.B. Baello, Jr., Quezon city, Philippines

09:15 LOW-DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN CHILDREN AND YOUNG ADULTS
D. De Wolf, B. Suys, L. Foubert, H. Verhaaren, Y. Taeymans, D. Matthys, Gent, Belgium

09:30 STRESS TESTING OF PATIENTS WITH LEFT BUNDLE BRANCH BLOCK EVALUATED IN A CHEST PAIN CENTER FOR ACUTE CARDIAC ISCHEMIA
M.G. Mikhail, S. Frederiksen, Ann Arbor MI, USA

09:45 STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH POOR ACOUSTIC WINDOWS: IS MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY ESSENTIAL?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany

10:00 IS A PACEMAKER INDICATED FOR VASOVAGAL PATIENTS WITH SEVERE CARDIO-INHIBITORY REFLEX AS IDENTIFIED BY THE ATP TEST? A PRELIMINARY RANDOMIZED TRIAL
D. Flammang, M. Antiel, T. Church, D. Hamani, E. Donal, Angouleme, France

10:15 PREDICTIVE VALUE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY FOR CARDIAC EVENTS IN PATIENTS PRESENTING WITH CHEST PAIN
A.J. McNeill, P. Seydak, M. McBurney, S.H. Barr, H.M. Dunn, J.A. Purvis, Londonderry N. Ireland, UK

10:30 CONTRIBUTION OF HEAD-UP TILT TEST AND ATP TEST IN ASSESSING THE MECHANISMS OF VASOVAGAL SYNDROME. INFERENCES TO THE THERAPEUTIC STRATEGY
D. Flammang, D. Hamani, E. Donal, M. Erickson, T. Church, Angouleme, France

10:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL09: Plenary Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY
Chairpersons:        M.D.J. Antunes, Coimbra, Portugal
                                J.S. Borer, New York NY, USA

10:45 THE BIOLOGY OF REGURGITANT VALVULAR DISEASES (Invited Lecture)
J. Borer, New York NY, USA

11:00 THE DIRECTIONS OF MITRAL REGURGITATION: THE "INS" AND "OUTS" OF THE MITRAL VALVE (Invited Lecture)
E.D. Wigle, Toronto ONT, Canada

11:15 OPEN MITRAL COMMISSUROTOMY (Invited Lecture)
M.D. Antunes, M.J. Antunes, Coimbra, Portugal

11:30 AORTIC VALVE SURGERY: A PROSPECTIVE AND RANDOMIZED STUDY OF MINISTERNOTOMY VERSUS CONVENTIONAL SURGERY
R.R. Dias, N.A.G. Stoff, Sao Paulo, Brazil

11:45 LEFT VENTRICULAR REMODELLING AFTER AORTIC VALVE REPLACEMENT WITH A FREESTYLE STENTLESS BIOPROSTHESIS
L.H.B. Baur, Y. Houdas, C.H. Peels, A. Prat, A.P. Kappetein, J. Braun, E.E. van der Wall, H.A. Huysmans, Leiden, The Netherlands

12:00 POISEUILLE'S MODEL (POIS-M) IS LESS FLOW-DEPENDENT AND MORE USEFUL IN DESCRIBING CIRCULATORY IMPAIRMENT IN AORTIC STENOSIS (AS) THAN TORRICELLI'S MODEL (TORR-M)
A. Malavasi, A. Tucconi, G. Di Girolamo, L. Cassisa, M. Pala, C. Poddighe, P. Masala, C. Denurra, A. Muretto, E. Solinas, Sassari, Italy

12:15 BALLOON MITRAL VALVULOPLASTY USING MODIFIED TECHNIQUE - OUR EXPERIENCE
C.N. Manjunath, K.H. Srinivas, C.B. Patil, H.V. Venkatesh, T.S. Bhoopal, C. Dhanalakshmi, S. Jayadeva, Bangalore, India

12:30 LONG-TERM OUTCOME OF OPERATED PATIENTS WITH CHRONIC AORTIC REGURGITATION AND EXTREME LEFT VENTRICULAR DILATATION
B. Ivanovic, D. Kalimanovska, D. Simic, D. Matic, B. Vujisic, D. Nikcevic, P. Djukic, Belgrade, Yugoslavia

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

PL10: Plenary Session
CLINICAL ASPECTS OF CORONARY ARTERY DISEASE
Chairpersons:        R.O. Cannon, III, Bethesda MD, USA
                                J.S. Forrester, Los Angeles CA, USA

10:45 Na-H EXCHANGE INHIBITION IN LIMITING ISCHEMIC INJURY - CLINICAL IMPLICATIONS (Invited Lecture)
S. Schaefer, Davis CA, USA

11:00 HEMOSTASIS AND INFLAMMATION IN ACUTE CORONARY SYNDROMES (Invited Lecture)
H.M. Hoffmeister, Tubingen, Germany

11:15 ASPIRIN INCREASES FERRITIN SYNTHESIS IN ENDOTHELIAL CELLS: A NOVEL ANTIOXIDANT PATHWAY (Invited Lecture)
H. Schroder, Halle (Saale), Germany

11:30 ARE NEW PHARMACOLOGICAL AGENTS SUPERIOR TO OLD DRUGS FOR TREATING PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE? EFFECTS ON SURVIVAL AND FUNCTIONAL STATUS (Invited Lecture)
U. Thadani, Oklahoma City OK, USA

11:45 IMPACT OF A HOSPITAL DISCHARGE PROTOCOL ON CORONARY ARTERY DISEASE TREATMENT UTILIZATION AND CLINICAL OUTCOMES (Invited Lecture)
G. Fonarow, Los Angeles CA, USA

12:00 VASCULAR EFFECTS OF ESTROGEN IN POSTMENOPAUSAL WOMEN AT RISK FOR CORONARY ARTERY DISEASE (Invited Lecture)
R.O. Cannon III, Bethesda MD, USA

12:15 ESTROGENS FOR THE PREVENTION OF CORONARY HEART DISEASE (Invited Lecture)
J.E. Rossouw, Bethesda MD, USA

12:30 CONTINUOUS COMBINED HORMONE REPLACEMENT DOES NOT INFLUENCE POSTPRANDIAL TRIGLYCERIDES IN WOMEN WITH CORONARY ATHEROSCLEROSIS
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Weizbicki, G. Jackson, London, UK

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

S70: SURGERY FOR LV DYSFUNCTION
Chairpersons:       V.S. Chekanov, Milwaukee WI, USA
                                W. Piccione Jr., Chicago IL, USA

10:45 LEFT VENTRICULAR DILATATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY SHOULD NOT EXCLUDE SURGICAL REVASCULARIZATION
R.W. Kim, B.S. Ugurlu, D.A. Tereb, G. Tellides, J.A. Elefteriades, New Haven CT, USA

11:00 QUALITY OF LIFE ASSESSMENT AFTER PARTIAL LEFT VENTRICULECTOMY
G. Bhat, M.A. Laureano, R.D. Dowling, P. Cerrito, Louisville KY, USA

11:15 DIASTOLIC FUNCTION IMPROVES PRIOR TO SYSTOLIC FUNCTION IN CRYOINJURED RABBIT HEARTS AFTER CELLULAR CARDIOMYOPLASTY
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA

11:30 TRANSPLANTED SKELETAL MYOBLASTS, BUT NOT FIBROBLASTS, EXPRESS CARDIAC AND SKELETAL CHARACTERISTICS AND IMPROVE PERFORMANCE OF INJURED MYOCARDIUM
K.A. Hutcheson, B.Z. Atkins, M.C. Reedy, D.D. Glower, D.A. Taylor, Durham NC, USA

11:45 LONG-TERM SURVIVAL AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICE FOR END-STAGE PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, B. Mihajlovic, S. Nicin, V. Torbica, M. Popov, D.D. Zecevic, A. Milosavljevic, S. Susak, B. Kozic, M. Golubovic, A. Redzek, Novi Sad, Yugoslavia

12:00 HEMODYNAMIC AND CLINICAL IMPROVEMENT AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICES IN END-STAGE HEART FAILURE IN PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, S. Nicin, B. Mihajlovic, M. Mijatov, S. Popovic, M. Popov, Z. Konstantinovic, D.D. Zecevic, S. Susak, A. Redzek, Novi Sad, Yugoslavia

12:15 DIFFERENTIAL EFFECTS OF MYOCARDIAL CRYOINJURY ON GLOBAL AND REGIONAL VENTRICULAR INDICES OF PERFORMANCE IN THE RABBIT HEART
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA

12:30 PREDICTION OF REGIONAL LEFT VENTRICULAR IMPROVEMENT AFTER CABG SURGERY: COMPARISON OF LOW DOSE DOBUTAMINE ECHOCARDIOGRAPHY (LDE) AND LOW DOSE DOBUTAMINE VENTRICULOGRAPHY (LDV)
L. Dalla Vecchia, T. Storti, P. Danna, C. Cogliati, S. Guzzetti, P. Di Biasi, R. Scrofani, A. Malliani, Milano, Italy

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

S55: BASIC RESEARCH, MOLECULAR CARDIOLOGY
Chairpersons:        L. Fananapazir, Bethesda MD, USA
                                A.C. Newby, Bristol, UK

10:45 IDENTIFICATION OF DENDRITIC CELLS IN AORTOCORONARY SAPHENOUS VEIN BYPASS GRAFTS: A POTENTIAL CAUSE OF GRAFT FAILURE
S.M. Cherian, Y.V. Bobryshev, S.J. Inder, R.S.A. Lord, H. Liang, A.E. Farnsworth, Sydney NSW, Australia

11:00 INDUCTION OF INTRACELLULAR ANTIOXIDANT ENZYMES SYSTEM BY GLUTIN - METABOLIC DRUG WITH ANTIISCHEMIC ACTION
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia

11:15 THE INSERTION/DELETION POLYMORPHISM WITHIN THE ANGIOTENSIN CONVERTING ENZYME AND REACTIVITY OF  ISOLATED RESISTANCE ARTERIES
R.P. Steeds, L. O'T